This document discusses fluoroquinolone (FQ) antibiotics. It begins by introducing FQs as synthetic antimicrobial agents derived from nalidixic acid, primarily active against gram-negative bacteria. The document then summarizes the development of FQs over time from the 1960s to 2000s, classifying them into first and second generations. It proceeds to discuss the mechanisms of action, resistance, and individual drug properties of various FQs such as ciprofloxacin, ofloxacin, levofloxacin, and moxifloxacin. The document concludes by outlining the therapeutic uses, pharmacokinetics, and adverse effects of FQs.